Ye-Fan Wang, Xin-Yue Ren, Wen Zhang and Guo-Wu Rao* Pages 2247 - 2266 ( 20 )
The sartans are a new class of antihypertensive drugs as angiotensin II receptor blockers which possess plenty of advantages in treating hypertension and related pathologies. This review describes the clinical treatment, side effects, and potential therapeutic effects of sartans from 1995 to date. The synthesis, structural-activity and molecular docking with Angiotensin Type 1 receptor of imidazole derivatives, benzimidazole derivatives and other compounds are also described. With a clear Structure-Activity Relationship and abundant pharmacological effects, some types of novel Angiotensin Type 1 receptor antagonists are emerging gradually for further research in the meantime.
Sartans, AT1 receptor blocker, renin-angiotensin system, structure-activity relationship, docking with AT1 receptor, synthesis.